Hookipa Pharma Inc Expected To Post A Loss Of 21 Cents A Share: Earnings Preview

Hookipa Pharma

08/08/2023 16:14

* HOOKIPA Pharma Inc  HOOK.OQ   HOOK.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 10. 
    * The New York City-based  company is expected to report  a
77.5% increase in revenue to $4.874 million from $2.75 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for HOOKIPA Pharma Inc
is for
a loss of 21 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $4​, above​ its last closing price of $0.73. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.22       -0.23      -0.27     Missed  -19.5
 Dec. 31 2023  -0.18       -0.21      -0.17     Beat    20.9
 Sep. 30 2022  -0.29       -0.28      -0.25     Beat    11.2​
 Jun. 30 2022  -0.36       -0.36      -0.23     Beat    36.1
 ​​Mar.        -0.24       -0.24      -0.40     Missed  -66.7
 31 2022                                                
 Dec. 31 2021  -0.63       -0.58      -0.65     Missed  -12.3​
 Sep. 30 2021  -0.52       -0.52      -0.61     Missed  -16.6
 Jun. 30 2021  -0.53       -0.53      -0.52     Beat    1.6
 This summary was machine generated August 8 at 15:14 GMT.  All
figures in US dollars  unless otherwise stated